ACUTE TREATMENT (n = 134) | Total (n = 134) n (%) | France (n = 37) n (%) | Germany (n = 32) n (%) | Italy (n = 19) n (%) | Spain (n = 26) n (%) | UK (n = 20) n (%) | p value |
Evaluation of efficacy | NS | ||||||
Patient perception | 100 (74.6%) | 30 (81.1%) | 23 (71.9%) | 14 (73.7%) | 17 (65.4%) | 16 (80.0%) | Â |
Patient diary | 81 (60.4%) | 21 (56.8%) | 20 (62.5%) | 12 (63.2%) | 19 (73.1%) | 9 (45.0%) | Â |
Validated scale | 16 (11.9%) | 3 (8.1%) | 4 (12.5%) | 2 (10.5%) | 23 (23.1%) | 1 (5.0%) | Â |
Frequency of evaluation of efficacy | NS | ||||||
Weekly | 16 (11.9%) | 6 (16.2%) | 5 (15.6%) | 2 (10.5%) | 1 (3.9%) | 2 (10.0%) | Â |
Monthly | 67 (50.0%) | 18 (48.7%) | 12 (37.5%) | 14 (73.7%) | 13 (50.0%) | 10 (50.0%) | Â |
Quarterly | 36 (26.9%) | 12 (32.4%) | 10 (31.3%) | 3 (15.8%) | 8 (30.8%) | 3 (15.0%) | Â |
Yearly | 2 (1.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (10.0%) | Â |
When patient comes and complains | 13 (9.7%) | 1 (2.7%) | 5 (15.6%) | 0 (0.0%) | 4 (15.3%) | 3 (15.0%) | Â |
PREVENTIVE TREATMENT (n = 118) | Total (n = 118) n (%) | France (n = 27) n (%) | Germany (n = 18) n (%) | Italy (n = 15) n (%) | Spain (n = 26) n (%) | UK (n = 32) n (%) | p value |
Evaluation of efficacy | NS | ||||||
Patient perception | 89 (75.4%) | 21 (77.7%) | 12 (66.6%) | 10 (66.6%) | 19 (73.1%) | 27 (84.4%) | Â |
Patient diary | 69 (58.5%) | 17 (62.9%) | 14 (77.7%) | 10 (66.6%) | 16 (61.5%) | 12 (37.5%) | Â |
Validated scale | 15 (13.7%) | 2 (7.4%) | 2 (11.1%) | 2 (13.3%) | 6 (23.1%) | 3 (9.4%) | Â |
Frequency of evaluation of efficacy | < 0.050 | ||||||
Weekly | 7 (5.9%) | 6 (22.2%) | 1 (5.5%) | 0 (0%) | 0 (0%) | 0 (0%) | Â |
Monthly | 47 (39.8%) | 9 (33.3%) | 5 (27.8%) | 8 (53.3%) | 13 (50.0%) | 12 (37.5%) | Â |
Quarterly | 48 (40.7%) | 12 (44.5%) | 9 (50.0%) | 7 (46.7%) | 9 (34.6%) | 11 (34.4%) | Â |
Yearly | 4 (3.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (12.5%) | Â |
When patient comes and complains | 12 (10.2%) | 0 (0%) | 3 (16.7%) | 0 (0%) | 4 (15.4%) | 5 (15.6%) | Â |